2023 international evidence-based guideline pcos glp-1 receptor agonist The dual impact of agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials Are GLP-1s The Future of
Description
GLP-1 receptor agonists and kidney protection
doi: 10.1111/jdi.12275 75 NauckMRizzoMJohnsonABosch-TrabergHMadsenJCariouB
A recent 20-week, phase II trial investigated the effects of subcutaneous administration of semaglutide 2.4 mg on gastric emptying, appetite, and energy intake in patients with obesity
Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence
138 In 2025, a multidisciplinary consensus statement by the Society of Perioperative Assessment and Quality Improvement provided a more nuanced, individualised approach influenced by the presence of significant GI symptoms, other patient-related factors and the indication for GLP-1 receptor agonist use
Its widely known that those conditions are driven by complex biological determinants, including genes, as well as environmental factors
